Descriptor English: | Interleukin-1 | ||||||
Descriptor Spanish: |
Interleucina-1
| ||||||
Descriptor Portuguese: | Interleucina-1 | ||||||
Descriptor French: | Interleukine-1 | ||||||
Entry term(s): |
Epidermal Cell Derived Thymocyte Activating Factor Epidermal Cell Derived Thymocyte-Activating Factor IL-1 Interleukin 1 Interleukin I Lymphocyte Activating Factor Lymphocyte-Activating Factor Macrophage Cell Factor T Helper Factor |
||||||
Tree number(s): |
D12.644.276.374.465.010 D12.644.276.374.500.400 D12.776.467.374.465.010 D12.776.467.374.500.400 D23.529.374.465.131 D23.529.374.500.400 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007375 | ||||||
Scope note: | A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Previous Indexing: |
Lymphocyte Transformation (1972-1982) Lymphocytes (1966-1971) Lymphokines (1974-1982) Macrophages (1966-1982) Toxins (1966-1973) |
||||||
Public MeSH Note: | 1990; see INTERLEUKIN 1 1983-1989 |
||||||
History Note: | 1990(1983) |
||||||
Related: |
Receptors, Interleukin-1
MeSH | ||||||
DeCS ID: | 29487 | ||||||
Unique ID: | D007375 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1983/01/01 | ||||||
Date of Entry: | 1982/04/29 | ||||||
Revision Date: | 2015/04/15 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Interleukin-1
- Preferred
Concept UI |
M0011503 |
Scope note | A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. |
Preferred term | Interleukin-1 |
Entry term(s) |
Epidermal Cell Derived Thymocyte Activating Factor Epidermal Cell Derived Thymocyte-Activating Factor IL-1 Interleukin 1 Interleukin I Lymphocyte Activating Factor Lymphocyte-Activating Factor Macrophage Cell Factor T Helper Factor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey